Advertisement
Advertisement
ONC
BeOne Medicines Ltd. - ADR
313.42
USDSponsored
+1.40
+0.45%
Apr 09, 16:00 UTC -4
Closed
Pre-Market
313.37
-0.05
-0.02%
ONC Earnings Reports
Positive Surprise Ratio
ONC beat 4 of 16 last estimates.
25%
Next Report
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$10.50B
/$0.49
Implied change from Q4 25 (Revenue/ EPS)
-1.10%
/+75.00%
Implied change from Q1 25 (Revenue/ EPS)
--
/--
BeOne Medicines Ltd. - ADR earnings per share and revenue
On Feb 26, 2026, ONC reported earnings of 0.28 USD per share (EPS) for Q4 25, missing the estimate of 0.62 USD, resulting in a -54.81% surprise. Revenue reached 10.62 billion, compared to an expected 10.96 billion, with a -3.11% difference. The market reacted with a -8.48% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of 0.49 USD, with revenue projected to reach 10.50 billion USD, implying an increase of 75.00% EPS, and decrease of -1.10% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Centessa Pharmaceuticals plc - ADR
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.38
Actual
-$0.48
Surprise
-23.58%
AleAnna, Inc. Class A Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-Actual
$0.00
Surprise
-
Lexeo Therapeutics, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.27
Surprise
+15.84%
Galectin Therapeutics Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.08
Surprise
+21.57%
Cardiol Therapeutics Inc. Class A Common Shares
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.07
Surprise
+14.22%
Actinium Pharmaceuticals, Inc
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-5.04%
Jupiter Neurosciences, Inc. Common Stock
Report Date
Apr 01, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.06
Surprise
+6.16%
Scienture Holdings, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$0.28
Actual
-$0.11
Surprise
+61.48%
Reviva Pharmaceuticals Holdings, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.19
Actual
-Surprise
-
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$2.32
Actual
-$2.34
Surprise
-0.62%
FAQ
What were BeOne Medicines Ltd. - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, BeOne Medicines Ltd. - ADR reported EPS of $0.28, missing estimates by -54.81%, and revenue of $10.62B, -3.11% below expectations.
How did the market react to BeOne Medicines Ltd. - ADR's Q4 2025 earnings?
The stock price moved down -8.48%, changed from $352.23 before the earnings release to $322.37 the day after.
When is BeOne Medicines Ltd. - ADR expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for BeOne Medicines Ltd. - ADR's next earnings report?
Based on --
analysts, BeOne Medicines Ltd. - ADR is expected to report EPS of $0.49 and revenue of $10.50B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement